Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Amoxicillin	O
/	O
Shellfish	O
/	O
orange	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Dyspnea	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
hx	O
of	O
asthma	O
on	O
2L	O
home	O
O2,	O
HFpEF	O
(LVEF	O
45%	O
___,	O
severe	O
aortic	O
stenosis	O
s/p	O
TAVR	O
(___)	O
c/b	O
___	O
cardiac	O
arrest,	O
coronary	O
artery	O
disease	O
status	O
post	O
CABG	O
complicated	O
by	O
in-stent	O
restenosis	O
___,	O
status	O
post	O
multiple	O
PCIs	O
with	O
persistent	O
stable	O
angina	O
(last	O
DES	O
to	O
___-Cx	O
___,	O
HTN,	O
HLD,	O
DM,	O
ESRD	O
on	O
HD	O
___	O
admitted	O
with	O
increasing	O
hypoxia	O
found	O
to	O
have	O
RML,	O
RLL	O
PNA	B-Lower_respiratory_tract_infection
on	O
CXR.	O
Per	O
report	O
patient	O
was	O
brought	O
in	O
from	O
her	O
SNF	O
after	O
2	O
hours	O
of	O
shortness	O
of	O
breath	O
and	O
tachypnea.	O
She	O
was	O
also	O
having	O
nausea	O
and	O
dry	O
heaves.	O
She	O
received	O
her	O
full	O
HD	O
session	O
on	O
___.	O
In	O
the	O
ED	O
she	O
was	O
given	O
zofran	O
with	O
no	O
effect.	O
She	O
was	O
briefly	O
placed	O
on	O
BiPAP	O
for	O
hypoxemic	O
hypercarbic	O
respiratory	O
failure	O
but	O
was	O
unable	O
to	O
tolerate	O
secondary	O
to	O
nausea.	O
ED	O
Course	O
notable	O
for:	O
Vitals:	O
T	O
101.8;	O
RR	O
28;	O
HR	O
62;	O
BP	O
109/55;	O
SpO2	O
94%	O
on	O
ventimask	O
Notable	O
Labs:	O
VBG:	O
pH	O
7.22;	O
pCO2	O
63;	O
HCO3	O
27	O
Lactate:	O
8.3	O
Trop:	O
0.22	O
Chem:	O
Na	O
136;	O
K	O
5.7;	O
BUN	O
20;	O
Cr	O
1.9	O
BNP:	O
>70,000	O
CBC:	O
WBC	O
8.8;	O
Hgb	O
10.2	O
CXR	O
showed:	O
RLL	O
PNA	B-Lower_respiratory_tract_infection
on	O
arrival	O
to	O
the	O
MICU	O
she	O
reports	O
mild	O
improvement	O
in	O
her	O
breathing	O
though	O
continues	O
to	O
feel	O
"lousy".	O
She	O
confirms	O
that	O
she	O
would	O
not	O
like	O
to	O
be	O
intubated	O
if	O
her	O
respiratory	O
status	O
were	O
to	O
deteriorate	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS	O
-	O
Type	O
2	O
diabetes	O
mellitus	O
with	O
nephropathy	O
and	O
retinopathy	O
-	O
Hypertension	O
-	O
Hyperlipidemia	O
2.	O
CARDIAC	O
HISTORY	O
-	O
CABG	O
___	O
-	O
TAVR	O
___	O
-	O
Congestive	O
heart	O
failure,	O
diastolic	O
dysfunction	O
(LVEF	O
46%	O
TTE	O
___	O
-	O
Cartotid	O
stenosis	O
s/p	O
CEA	O
-	O
TIA	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
-	O
ESRD	O
___	O
DM/HTN)	O
on	O
HD	O
___	O
-	O
Chronic	O
anemia	O
likely	O
secondary	O
to	O
chronic	O
renal	O
insufficiency	O
-	O
Iron	O
deficiency	O
anemia	O
-	O
Asthma	O
(FVC	O
66%,	O
FEV1	O
76%)	O
-	O
Diverticulosis	O
-	O
Gout	O
-	O
Temporal	O
arteritis	O
Social	O
History:	O
___	O
Family	O
History:	O
-	O
Mother	O
had	O
MI	O
in	O
her	O
___	O
-	O
Grandmother	O
had	O
diabetes	O
-	O
Father	O
passed	O
away	O
in	O
an	O
accident	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:	O
Afebrile	O
HR	O
69,	O
BP	O
116/59	O
RR	O
30	O
O2	O
SAT	O
100	O
%	O
on	O
___	O
mask	O
GENERAL:	O
Alert,	O
oriented,	B-Delirium
in	O
mild	O
respiratory	O
distress	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear	O
NECK:	O
supple	O
LUNGS:	O
Diffuse	O
rhonchi	O
throughout	O
right	O
lower	O
lung	O
field,	O
speaking	O
in	O
>3	O
word	O
sentences	O
without	O
difficulty	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
___	O
systolic	O
murmur	O
at	O
apex	O
ABD:	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
EXT:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
SKIN:	O
no	O
rash	O
NEURO:	O
AOx3,	B-Delirium
moving	O
4	O
extremities	O
with	O
purpose	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
Patient	O
expired.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
05:15AM	O
BLOOD	O
WBC-8.8	O
RBC-3.55*	O
Hgb-10.2*	O
Hct-34.9	O
MCV-98	O
MCH-28.7	O
MCHC-29.2*	O
RDW-17.9*	O
RDWSD-65.0*	O
Plt	O
___	O
___	O
05:15AM	O
BLOOD	O
Glucose-97	O
UreaN-20	O
Creat-1.9*	O
Na-136	O
K-5.7*	O
Cl-94*	O
HCO3-21*	O
AnGap-21*	O
___	O
05:15AM	O
BLOOD	O
proBNP->70000*	O
___	O
12:30PM	O
BLOOD	O
Calcium-8.8	O
Phos-3.3	O
Mg-1.4*	O
___	O
05:26AM	O
BLOOD	O
___	O
pO2-14*	O
pCO2-63*	O
pH-7.22*	O
calTCO2-27	O
Base	O
XS--5	O
___	O
05:26AM	O
BLOOD	O
Lactate-8.3*	O
IMAGING	O
STUDIES:	O
================	O
CXR	O
___	O
1.	O
Consolidative	O
right	O
mid	O
and	O
lower	O
lung	O
airspace	O
opacities	O
with	O
air	O
bronchograms	O
consistent	O
with	O
pneumonia.	B-Lower_respiratory_tract_infection
2.	O
Persistent	O
moderate	O
cardiomegaly	O
and	O
small	O
bilateral	O
pleural	O
effusions,	O
right	O
greater	O
than	O
left.	O
MICROBIOLOGY:	O
=============	O
__________________________________________________________	O
___	O
3:55	O
am	O
STOOL	O
CONSISTENCY:	O
SOFT	O
Source:	O
Stool.	O
**FINAL	O
REPORT	O
___	O
C.	O
difficile	O
PCR	O
(Final	O
___:	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
ON	O
___	O
AT	O
3PM.	O
POSITIVE.	O
(Reference	O
Range-Negative).	O
The	O
C.	O
difficile	O
PCR	O
is	O
highly	O
sensitive	O
for	O
toxigenic	O
strains	O
of	O
C.	O
difficile	O
and	O
detects	O
both	O
C.	O
difficile	O
infection	O
(CDI)	O
and	O
asymptomatic	O
carriage.	O
Therefore,	O
positive	O
C.	O
diff	O
PCR	O
tests	O
trigger	O
reflex	O
C.	O
difficile	O
toxin	O
testing,	O
which	O
is	O
highly	O
specific	O
for	O
CDI.	O
C.	O
difficile	O
Toxin	O
antigen	O
assay	O
(Final	O
___:	O
POSITIVE.	O
(Reference	O
Range-Negative).	O
PERFORMED	O
BY	O
EIA.	O
This	O
result	O
indicates	O
a	O
high	O
likelihood	O
of	O
C.	O
difficile	O
infection	O
(CDI).	O
__________________________________________________________	O
___	O
6:17	O
am	O
BLOOD	O
CULTURE	O
Source:	O
Line-dialysis	O
#1.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
DISCHARGE	O
LABS	O
(PATIENT	O
EXPIRED	O
___:	O
=====================================	O
___	O
07:00AM	O
BLOOD	O
WBC-5.7	O
RBC-2.63*	O
Hgb-7.7*	O
Hct-24.1*	O
MCV-92	O
MCH-29.3	O
MCHC-32.0	O
RDW-19.5*	O
RDWSD-61.3*	O
Plt	O
___	O
___	O
07:00AM	O
BLOOD	O
Glucose-76	O
UreaN-20	O
Creat-2.3*	O
Na-139	O
K-4.2	O
Cl-97	O
HCO3-28	O
AnGap-14	O
___	O
01:40PM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.35*	O
___	O
07:00AM	O
BLOOD	O
Calcium-8.5	O
Phos-3.2	O
Mg-1.9	O
Brief	O
Hospital	O
Course:	O
SUMMARY:	O
========	O
___	O
was	O
a	O
___	O
with	O
a	O
PMH	O
significant	O
for	O
HFpEF	O
(LVEF	O
45%	O
___,	O
severe	O
aortic	O
stenosis	O
s/p	O
TAVR	O
(___)	O
c/b	O
___	O
cardiac	O
arrest,	O
coronary	O
artery	O
disease	O
status	O
post	O
CABG	O
complicated	O
by	O
in-stent	O
restenosis	O
___,	O
status	O
post	O
multiple	O
PCIs	O
with	O
persistent	O
stable	O
angina	O
(last	O
DES	O
to	O
LMCA-Cx	O
___,	O
HTN,	O
HLD,	O
DM,	O
ESRD	O
on	O
HD	O
___	O
admitted	O
with	O
increasing	O
hypoxia	O
and	O
pneumonia.	B-Lower_respiratory_tract_infection
She	O
was	O
treated	O
with	O
vancomycin	O
and	O
cefepime	O
for	O
pneumonia.	B-Lower_respiratory_tract_infection
She	O
developed	O
chest	O
pressure	O
consistent	O
with	O
angina	O
on	O
___	O
following	O
dialysis.	O
She	O
was	O
noted	O
to	O
have	O
troponin	O
leak	O
and	O
ECG	O
was	O
unchanged	O
from	O
prior,	O
consistent	O
with	O
demand	O
NSTEMI.	O
SL	O
Nitro	O
and	O
IV	O
morphine	O
were	O
given	O
with	O
improvement	O
in	O
pain.	O
In	O
the	O
evening	O
of	O
___,	O
she	O
complained	O
of	O
generalized	O
body	O
pain	O
and	O
was	O
given	O
Tylenol.	O
On	O
the	O
evening	O
of	O
___,	O
nursing	O
staff	O
found	O
the	O
patient	O
to	O
be	O
unresponsive.	O
MD	O
was	O
called	O
to	O
bedside.	O
On	O
exam,	O
pulses	O
could	O
not	O
be	O
appreciated,	O
and	O
heartbeat	O
and	O
respirations	O
were	O
absent.	O
Pupils	O
were	O
fixed	O
and	O
dilated.	O
DNR/DNI	O
code	O
status	O
had	O
been	O
confirmed	O
with	O
the	O
patient	O
earlier	O
in	O
the	O
admission,	O
and	O
CPR	O
was	O
not	O
attempted.	O
The	O
patient	O
passed	O
away	O
at	O
2215	O
on	O
___.	O
Next	O
of	O
kin	O
(son	O
___,	O
her	O
HCP)	O
had	O
visited	O
earlier	O
that	O
day.	O
He	O
was	O
contacted	O
and	O
declined	O
autopsy.	O
ACUTE	O
ISSUES	O
DURING	O
HOSPITALIZATION:	O
====================================	O
#Type	O
II	O
NSTEMI	O
Patient	O
has	O
history	O
of	O
multi-vessel	O
CAD,	O
and	O
multiple	O
admissions	O
for	O
chest	O
pain	O
related	O
to	O
HD	O
sessions.	O
Reported	O
recurrence	O
of	O
chest	O
pressure	O
after	O
HD	O
___.	O
Gave	O
sublingual	O
nitro	O
x	O
1,	O
IV	O
morphine	O
2mg,	O
with	O
improvement	O
in	O
pain.	O
EKG	O
unchanged	O
from	O
prior.	O
Troponins	O
0.35	O
(prior	O
baseline	O
around	O
0.2-0.3).	O
Did	O
not	O
have	O
morning	O
anti-anginal	O
medications	O
prior	O
to	O
HD,	O
so	O
these	O
were	O
administered,	O
and	O
chest	O
pain	O
resolved	O
throughout	O
the	O
day.	O
Trop	O
leak	O
thought	O
most	O
likely	O
___	O
demand,	O
given	O
known	O
underlying	O
coronary	O
disease,	O
and	O
given	O
her	O
chest	O
pain	O
occurred	O
in	O
the	O
setting	O
of	O
HD.	O
She	O
was	O
not	O
heparinized,	O
as	O
most	O
likely	O
that	O
this	O
represented	O
demand	O
ischemia,	O
and	O
pain	O
resolved	O
with	O
anti-anginal	O
medications.	O
#C.	O
Diff	O
Noted	O
to	O
have	O
non-bloody,	O
watery	O
diarrhea,	O
beginning	O
___.	O
Had	O
10	O
bowel	O
movements	O
per	O
report.	O
Has	O
history	O
of	O
C.Diff	O
and	O
recently	O
on	O
broad	O
spectrum	O
antibiotics,	O
including	O
fluoroquinolone.	O
C.	O
Diff	O
positive.	O
Treated	O
with	O
vanc	O
QID.	O
#Acute	O
hypoxemic,	O
hypercarbic	O
respiratory	O
Failure	O
#HAP	I-Lower_respiratory_tract_infection
#Respiratory	O
acidosis	O
w/	O
secondary	O
metabolic	O
acidosis	O
Patient	O
was	O
presenting	O
from	O
home	O
with	O
2	O
hours	O
of	O
increasing	O
shortness	O
of	O
breath	O
and	O
dyspnea.	O
CXR	O
in	O
ED	O
showed	O
right	O
sided	O
consolidation	O
consistent	O
with	O
pneumonia.	B-Lower_respiratory_tract_infection
S/p	O
Vanc	O
and	O
Zosyn	O
in	O
the	O
ED.	O
She	O
might	O
also	O
have	O
component	O
of	O
heart	O
failure	O
given	O
elevated	O
BNP.	O
She	O
was	O
briefly	O
on	O
BiPAP	O
requiring	O
ICU,	O
then	O
de-escalated	O
to	O
only	O
2	O
liters	O
nasal	O
cannula	O
(which	O
is	O
her	O
home	O
O2	O
dose)	O
and	O
transferred	O
to	O
medicine	O
floor.	O
She	O
completed	O
7	O
day	O
course	O
PO	O
Levaquin	O
(D1:	O
___.	O
Volume	O
managed	O
with	O
HD	O
as	O
below.	O
CHRONIC	O
ISSUES	O
DURING	O
HOSPITALIZATION:	O
======================================	O
#CAD	O
s/p	O
CABG	O
#Type	O
2	O
NSTEMI	O
Patient	O
has	O
history	O
of	O
multi-vessel	O
CAD.	O
She	O
is	O
s/p	O
CABG	O
___	O
patent	O
saphenous	O
vein	O
graft	O
to	O
diagonal,	O
left	O
internal	O
mammary	O
artery	O
to	O
left	O
anterior	O
descending,	O
stent	O
of	O
left	O
circumflex	O
and	O
OM1	O
(re-stented	O
in	O
___,	O
and	O
stent	O
and	O
brachytherapy	O
to	O
OM2	O
with	O
unrevascularizable	O
LCx	O
system	O
cath	O
in	O
___	O
and	O
PCI	O
on	O
___	O
with	O
DES	O
to	O
Cx	O
and	O
POBAs.	O
Continued	O
home	O
ASA,	O
Atorvastatin,	O
Plavix.	O
Imdur	O
was	O
reduced	O
further	O
to	O
60	O
mg	O
BID	O
___	O
and	O
amlodipine	O
was	O
held	O
for	O
BP	O
90-100s.	O
#Ischemic	O
cardiomyopathy	O
Last	O
TTE	O
with	O
EF	O
45%	O
in	O
___.	O
No	O
evidence	O
of	O
overload	O
on	O
exam.	O
Volume	O
managed	O
with	O
HD.	O
#Asthma	O
Continued	O
montelukast,	O
duonebs,	O
fluticasone	O
inhaler.	O
#ESRD	O
Continued	O
HD	O
M,	O
W,	O
F.	O
#Type	O
2	O
diabetes	O
mellitus:	O
Last	O
HgbA1c	O
6.1,	O
DM	O
with	O
nephropathy	O
and	O
retinopathy.	O
Treated	O
with	O
ISS	O
while	O
inpatient.	O
#Anemia	O
of	O
chronic	O
disease	O
She	O
remains	O
anemic,	O
likely	O
___	O
decreased	O
production	O
of	O
erythropoietin	O
in	O
the	O
setting	O
of	O
ESRD.	O
Treated	O
with	O
EPO	O
during	O
HD.	O
#Hypertension	O
Reduced	O
Imdur,	O
held	O
amlodpine	O
in	O
the	O
setting	O
of	O
BP	O
90-100s.	O
#Hyperlipidemia	O
Continue	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM.	O
#Hypothyroidism	O
Continued	O
home	O
levothyroxine.	O
#GERD	O
Continued	O
home	O
pantoprazole.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
albuterol	O
sulfate	O
90	O
mcg/actuation	O
inhalation	O
Q6H:PRN	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
4.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
M,	O
WED,	O
FRI	O
5.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
6.	O
Fluticasone	O
Propionate	O
110mcg	O
2	O
PUFF	O
IH	O
DAILY	O
7.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
DAILY	O
8.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
240	O
mg	O
PO	O
DAILY	O
9.	O
Latanoprost	O
0.005%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
QHS	O
10.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
___	O
11.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
SUN	O
12.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
13.	O
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
14.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
15.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
16.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
17.	O
Senna	O
17.2	O
mg	O
PO	O
BID	O
18.	O
Thiamine	O
100	O
mg	O
PO	O
DAILY	O
19.	O
B	O
complex	O
with	O
C#20-folic	O
acid	O
1	O
mg	O
oral	O
DAILY	O
20.	O
mometasone-formoterol	O
200-5	O
mcg/actuation	O
inhalation	O
BID	O
21.	O
amLODIPine	O
2.5	O
mg	O
PO	O
DAILY	O
22.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
BID	O
Discharge	O
Medications:	O
N/A	O
Discharge	O
Disposition:	O
Expired	O
Discharge	O
Diagnosis:	O
#Multifocal	O
PNA	B-Lower_respiratory_tract_infection
#C.	O
Diff	O
colitis	O
#ESRD	O
on	O
HD	O
#NSTEMI	O
Discharge	O
Condition:	O
N/A	O
Discharge	O
Instructions:	O
N/A	O
Followup	O
Instructions:	O
___	O

